Skip to main content
European Commission logo print header

a Study of the Epigenetic Alterations that Result in Cardiac Hypertrophy

Obiettivo

Heart failure is a major cause of mortality and morbidity, and often the consequence of pathological cardiac hypertrophy. Upon entering hypertrophy, cells undergo a vast transcriptional remodelling, with thousands of genes being either up- or down-regulated. In the last years it became evident that epigenetic modifications are an important determinant of transcriptional changes, and several lines of evidence demonstrate that epigenome modulating enzymes are implicated in cardiac hypertrophy. In the present project we propose to study transcriptional repression by DNA and histone methylation. We will map these modifications and use this map to identify and study the methyl transferases, transcription factors and pathways that underlie these modifications using a systems-biology approach. The insight that is to be anticipated from this study will not only enhance our understanding of transcription regulation in hypertrophy, it can also provide a novel entry point for strategies to treat this disorder.

Invito a presentare proposte

FP7-PEOPLE-2009-IEF
Vedi altri progetti per questo bando

Coordinatore

THE BABRAHAM INSTITUTE
Contributo UE
€ 171 740,80
Indirizzo
Babraham Hall
CB22 3AT Cambridge
Regno Unito

Mostra sulla mappa

Regione
East of England East Anglia Cambridgeshire CC
Tipo di attività
Research Organisations
Contatto amministrativo
Fang Gao (Ms.)
Collegamenti
Costo totale
Nessun dato